Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
BioLife Solutions
BLFS
Concentration Risk %
Concentration Risk % at other companies
Enovix Corporation
ENVX
83%
+36.0pp
Heartland Express
HTLD
32%
+6.0pp
Weis Markets
WMK
100%
0.0pp
Innoviva, Inc.
INVA
36%
+7.0pp
Vishay Precision Group
VPG
25%
0.0pp
RPM International
RPM
6%
+0.2pp
Segments
By geography
See full
Europe, Middle East, Africa (EMEA)
14%
-6.7%
Other
6%
+20.0%
By product
See full
CryoStor
82%
-2.4%
Other financials
Income statement
See full
Revenue
$27.5M
+24.7%
Gross profit
$17.5M
+18.2%
Operating income
$27.0K
+105%
Net income
$1.2M
+365%
EPS (diluted)
$0.02
—
Balance sheet
See full
Cash & equivalents
$22.8M
-65.9%
Total debt
$17.4M
-35.6%
Total equity
$372.2M
+5.6%
Total assets
$400.9M
+1.5%
Cash flow
See full
Operating cash flow
-$491.0K
-128%
CapEx
$167.0K
-4.6%
Free cash flow
-$658.0K
-142%
Valuation
See full
Market cap
$1.34B
+33.1%
Enterprise value
$1.34B
+38.1%
P/S
13.5×
+0.6×
Profitability
See full
Gross margin
66.9%
—
Operating margin
-16.7%
—
Net margin
-68.7%
—
FCF margin
-15.9%
+18.7pp
Returns & leverage
See full
Return on equity
-14.5%
-4.7pp
Debt / equity
0×
0.0×
Current ratio
7.3×
+2.6×